AXS-12 Reduces Cataplexy, Sleepiness in Narcolepsy

Watchdoq April 11, 2025
(MedPage Today) -- SAN DIEGO -- AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed.
From baseline, patients treated...

Read Full Article